Ambroxol for the treatment of chronic pain
AssigneeBoehringer Ingelheim Pharma GmbH & Co. KG
InventorsWolfram Gaida, Klaus Klinder, Thomas Weiser
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of ambroxol and the pharmacologically acceptable salts thereof for preparing a pharmaceutical composition for the treatment of diseases which are based on a powerful activation of voltage-dependent sodium channels, particularly for the treatment of chronic pain.
Claims7
A method for teating diseases or conditions which are based on a powerful activation of voltage-dependent sodium channels, which method comprises administering to a host suffering from such a disease a therapeutically effective amount of ambroxol or a pharmacologically acceptable salt thereof.
Dependencies are inferred from the claim text.